 |
Note: This product can only ship to a medical or an educational facility.
The BD Veritor System for Rapid Detection of SARS-CoV-2 is a chromatographic immunoassay for the direct and qualitative detection of SARS-CoV-2 antigens in nasal swabs from patients with signs and symptoms who are suspected of COVID-19.
Features and Benefits
- Simplify the testing process
- Easy operation and 1-button functionality may potentially reduce manual test processing errors
- Enables intuitive sample processing with prefilled, unitized tubes color-coded by reagent or assay type
- Achieve
fast, reliable results
- Displays easy-to-read digital results for SARS-CoV-2 in 15 minutes
- Records results on secured drive
- Advanced particle technology enhances sensitivity by using a proprietary process to produce highly stable, modified colloidal metal particles, helping improve test performance.
- Adaptive read technology helps improve specificity
to reduce false-positive results by compensating for
background and nonspecific binding
- Comes in a box of 30 test kits
- Authorized by the FDA under an EUA, pending FDA clearance / approval
- CLIA Waived
- Works with the BD Veritor™ Plus System Analyzer (BD Veritor Analyzer is required to use this test kit)
Materials Included
- (30) single use test devices
- (30) single use reaction tubes, each with 325 µL extraction reagent and an integral dispensing tip
- (30) sterile, single use specimen sampling swabs
- (1) SARS-CoV-2 (+) control swab for single use
- (1) SARS-CoV-2 (-) control swab for single use
- Instructions for use
CPT Code
- 87426 - Infectious agent antigen detection by immunoassay technique (e.g., enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative, multiple-step method; severe acute respiratory syndrome coronavirus (e.g., SARS-CoV, SARS-CoV-2 [COVID-19])
Documentation
User Manual
|
|
|
Skip to content
Exactly as described 
